Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02601950
Brief Title: A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma

First Submitted : October 21, 2015
First Submitted that Met QC Criteria : November 9, 2015
First Posted : November 11, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : May 20, 2021
Last Update Posted : May 24, 2021